Equities

Key statistics

As of last trade Novartis AG (NVSEF:PKC) traded at 76.00, -9.31% below its 52-week high of 83.80, set on Jul 29, 2016.
52-week range
Today
66.35Dec 08 201683.80Jul 29 2016
Markit short selling activity
Low
Med
High
Open75.35
High76.00
Low75.35
Bid--
Offer--
Previous close73.40
Average volume3.03k
Shares outstanding2.63bn
Free float2.47bn
P/E (TTM)26.60
Market cap194.61bn CHF
EPS (TTM)2.79 CHF
Annual div (ADY)2.73 USD
Annual div yield (ADY)3.71%
Div ex-dateMar 01 2017
Div pay-dateMar 06 2017
Data delayed at least 15 minutes, as of Apr 25 2017 17:07 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.